Search for: "LILLI JOHNSON" Results 101 - 120 of 242
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2012, 8:08 am by Cal Warriner
That is the amount the Johnson & Johnson (J&J) has agreed to set aside to settle a government probe and lawsuits involving the illegal marketing of its Risperdal antipsychotic drug. [read post]
13 Apr 2012, 7:19 am by admin
That same year, Eli Lilly pleaded guilty to criminal conduct involving its marketing of the antipsychotic drug Zyprexa and agreed to pay $1.4 billion in fines. [read post]
23 Mar 2012, 7:31 am by Joshua Matz
  At The Hill, Mike Lillis reports on Nancy Pelosi’s characterization of the Affordable Care Act as “iron-clad constitutionally. [read post]
14 Mar 2012, 8:57 am
 A stellar cast of corporations, including those who create their own IP and those who thrive by using the IP of others, is attending: BAE Systems, Boeing Company, Caterpillar, Colgate-Palmolive [will they give a speakers a pasting, wonders Merpel], Eli Lilly, Hitachi, IBM, Johnson & Johnson, Mastercard, Microsoft, NASA, Pfizer,Rambus, Teva, and many more, too numerous to sue list. [read post]
12 Mar 2012, 8:13 am by Ronald Collins
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
9 Mar 2012, 1:12 pm by Pilar G. Kraman
Other speakers include: • David Kappos, undersecretary of commerce for intellectual property and director, USPTO • Judge Paul Michel • Gary Griswold, president and chief intellectual property counsel, 3M Innovative Properties Company and former chairman, 21st Century Patent Reform • Bob Stoll, former commissioner, USPTO and partner, Drinker Biddle & Reath • Robert Armitage, senior VP and general counsel, Eli Lilly • Steven Wood, patent… [read post]
6 Feb 2012, 5:57 am by Pilar G. Kraman
Speakers: • Judge Paul Michel • Gary Griswold, former chairman, The Coalition for 21st Century Patent Reform • Bob Stoll, former commissioner for USPTO • Robert Armitage, senior VP and general counsel, Eli Lilly • Phil Johnson, chief intellectual property counsel, Johnson & Johnson • Sherry Knowles, principle, Knowles Intellectual Property Strategies • F. [read post]
5 Feb 2012, 5:01 pm by Lawrence Higgins
Eli Lilly's profit dropped 27% because of Zyprexa going generic. [read post]
16 Jan 2012, 7:03 am
Matos’ Stevens-Johnson syndrome lawsuit claims that Eli Lilly failed to adequately warn doctors and patients that Cymbalta side effects could cause dangerous skin reactions. [read post]
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Johnson & Johnson, 647 F.3d 1353, 1366 (Fed. [read post]
2 Dec 2011, 2:00 pm by Bexis
Eli Lilly Co., 2011 WL 2621067, at *3 (E.D. [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Merck, Johnson & Johnson, Eli Lilly and Bristol-Myers Squibb also cut jobs. [read post]